Ardelyx (ARDX) Receivables - Other (2018 - 2020)

Ardelyx (ARDX) posted Receivables - Other of $750000.0 for Q3 2020, little changed on a QoQ basis from $750000.0 in Q2 2020.

Ardelyx (ARDX) Receivables - Other (2018 - 2020) Analysis & Trends

Ardelyx's Receivables - Other history runs 3 years deep, the most recent figure standing at $750000.0 for Q3 2020.

Quarterly Receivables - Other changed N/A year-over-year to $750000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $750000.0 (changed N/A YoY) and the FY2019 annual result came in at $750000.0, down 85.0% from the prior year.
Receivables - Other was $750000.0 for Q3 2020 at Ardelyx, roughly flat from $750000.0 in the prior quarter.
Across five years, Receivables - Other topped out at $5.0 million in Q1 2018 and bottomed at $750000.0 in Q4 2019.
A 3-year average of $2.9 million and a median of $2.9 million in 2018 frame the typical range for Receivables - Other.
Peak annual rise in Receivables - Other reached 85.0% in 2019, while the deepest fall reached 85.0% in 2019.
Ardelyx's Receivables - Other stood at $5.0 million in 2018, then slumped by 85.0% to $750000.0 in 2019, then changed by 0.0% to $750000.0 in 2020.
Business Quant data shows ARDX's Receivables - Other at $750000.0 in Q3 2020, $750000.0 in Q2 2020, and $750000.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Ardelyx	1.26 Bn	1.02 Bn	89.66 Mn

Download Data